Investa Office Fund (ASX:IOF) today announces it has executed an Agreement For Lease (AFL) with Pfizer Australia Pty Ltd (Pfizer) at Barrack Place, 151 Clarence Street, Sydney across 4,640sqm, comprising the top four floors of the 18 level building for an eight year term commencing in December 2018. Pfizer is one of the world’s leading biopharmaceutical companies, developing and producing an extensive range of medicines and vaccines. Click here to access Pfizer's Media Release.
The AFL to Pfizer represents 21% of the building’s Net Lettable Area (NLA) on completion and extends the total precommitment at Barrack Place from 35% to 57% of total NLA.

Penny Ransom, IOF Fund Manager said, “Attracting such a high calibre tenant as Pfizer at IOF’s Barrack Place development is an outstanding result for the Fund and is testament to the quality of the building and the specialist development capability at Investa. We are also very pleased to welcome Pfizer as a valued partner to our platform.”

The Green Building Council of Australia has also awarded Barrack Place development a 6 Star Green Star Office Design rating. This represents an upgrade from the original 5 Star target, which was achieved through adopting a lifecycle assessment pathway for the materials strategy and obtaining the maximum number of innovation points available. The development of Barrack Place is progressing as planned with completion anticipated in October 2018.

Click below image to see a sneak peek of Barrack Place, 151 Clarence St, Sydney